Revolution Medicines, Inc. RVMD Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $440.94M+32.2% | $383.75M-29.3% | $217.44M+8.0% | $402.44M+46.0% | $333.55M+15.6% | ||
| $1.47B-17.1% | $1.64B-6.0% | $1.71B+27.1% | $1.73B+31.9% | $1.77B+25.0% | ||
| $4.86M+31.4% | $4.86M+31.4% | $4.86M+68.2% | $3.92M+29.2% | $3.7M+22.0% | ||
| $194.44M+45.2% | $166.51M+30.4% | $155.49M+35.9% | $139.17M+45.4% | $133.91M+86.5% | ||
| $1.97B-7.8% | $2.08B-10.9% | $1.98B+25.2% | $2.18B+34.0% | $2.13B+23.4% | ||
| $31.48M+15.9% | $33.19M+36.7% | $32.93M+32.7% | $33.05M+30.7% | $27.15M+14.6% | ||
| $129.9M+12.2% | $132.08M+12.4% | $134.45M+80.9% | $114M+51.4% | $115.78M+52.0% | ||
| $14.61M0.0% | $14.61M0.0% | $14.61M0.0% | $14.61M0.0% | $14.61M0.0% | ||
| $55.8M-1.1% | $55.8M-1.5% | $55.87M-1.9% | $56.14M-1.9% | $56.4M-1.9% | ||
| $14.48M+10.3% | $14.78M+748% | $14.87M+44.7% | $31.42M+280% | $13.13M+216% | ||
| $2.25B-4.7% | $2.35B-8.0% | $2.25B+27.7% | $2.43B+34.3% | $2.37B+23.9% | ||
| $276.76M+77.7% | $243.73M+73.4% | $233.54M+57.9% | $183.15M+19.6% | $155.71M+1.4% | ||
| $16.61M+28.0% | $16.47M+27.9% | $16.33M+94.4% | $13.09M+57.1% | $12.98M+58.9% | ||
| $289.6M+82.6% | $290.42M+77.2% | $245.62M+122% | $184.53M+75.2% | $158.6M+69.2% | ||
| $140.02M+15.4% | $142.23M+15.7% | $142.14M+81.5% | $119.7M+51.4% | $121.36M+52.0% | ||
| $156.63M+16.6% | $158.7M+16.8% | $158.46M+82.8% | $132.79M+51.9% | $134.34M+52.6% | ||
| $6.88M+66.2% | $1.21M+80.3% | $2.48M+50.8% | $7.2M+998% | $4.14M+36.1% | ||
| $753.82M+162% | $723.21M+147% | $655.02M+233% | $564.2M+198% | $287.2M+57.0% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $19K+5.6% | $19K+5.6% | $18K+12.5% | $18K+12.5% | $18K+12.5% | ||
| $4.82B+19.8% | $4.5B+12.4% | $4.1B+31.9% | $4.06B+35.1% | $4.03B+35.1% | ||
| -$3.32B-70.3% | -$2.87B-65.1% | -$2.5B-62.3% | -$2.2B-58.6% | -$1.95B-55.6% | ||
| -$622K-136% | $3.24M+145% | $3.12M-18.3% | $1.3M+170% | $1.71M+242% | ||
| $1.5B-27.8% | $1.63B-28.0% | $1.6B+2.0% | $1.87B+15.2% | $2.08B+20.4% | ||
| $2.25B-4.7% | $2.35B-8.0% | $2.25B+27.7% | $2.43B+34.3% | $2.37B+23.9% | ||
| $1.47B-17.1% | $1.64B-6.0% | $1.71B+27.1% | $1.73B+31.9% | $1.77B+25.0% | ||
| $14.48M+10.3% | $14.78M+748% | $14.87M+44.7% | $31.42M+280% | $13.13M+216% | ||
| —— | —— | —— | —— | —— | ||
| $129.9M+12.2% | $132.08M+12.4% | $134.45M+80.9% | $114M+51.4% | $115.78M+52.0% | ||
| $55.8M-1.1% | $55.8M-1.5% | $55.87M-1.9% | $56.14M-1.9% | $56.4M-1.9% | ||
| $129.9M+12.2% | $132.08M+12.4% | $134.45M+80.9% | $114M+51.4% | $115.78M+52.0% | ||
| $14.48M+10.3% | $14.78M+748% | $14.87M+44.7% | $31.42M+280% | $13.13M+216% | ||
| $129.9M+12.2% | $132.08M+12.4% | $134.45M+80.9% | $114M+51.4% | $115.78M+52.0% | ||
| $14.48M+10.3% | $14.78M+748% | $14.87M+44.7% | $31.42M+280% | $13.13M+216% | ||
| $280.64M— | —— | —— | —— | —— | ||
| $192.45M+96.2% | $209.34M+117% | $154.45M+98.0% | $114.69M+69.4% | $98.11M+84.5% | ||
| $4.82B+19.8% | $4.5B+12.4% | $4.1B+31.9% | $4.06B+35.1% | $4.03B+35.1% | ||
| $19K+5.6% | $19K+5.6% | $18K+12.5% | $18K+12.5% | $18K+12.5% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $280.64M— | —— | —— | —— | —— | ||
| $2.35M0.0% | $2.35M0.0% | $2.35M-24.5% | $2.35M-24.5% | $2.35M-24.5% | ||
| $34.33M+4,477% | $18.55M+482% | $5.92M+114% | $5.33M— | $750K— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Revolution Medicines, Inc.'s total assets?
- Revolution Medicines, Inc. (RVMD) holds $2.3B in total assets, down 4.7% year over year.
- How much debt does Revolution Medicines, Inc. have?
- Revolution Medicines, Inc. carries $156.6M in total debt against $1.5B of shareholders' equity, a debt-to-equity ratio of 0.10.
- How much cash does Revolution Medicines, Inc. have?
- Revolution Medicines, Inc. holds $440.9M in cash and equivalents.
- Can Revolution Medicines, Inc. cover its short-term obligations?
- Its current ratio is 6.80 — current assets exceed current liabilities.
- Where does Revolution Medicines, Inc.'s balance sheet data come from?
- Every line is extracted from Revolution Medicines, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.